New Zealand markets close in 2 hours 4 minutes

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.49-0.28 (-2.19%)
At close: 04:00PM EDT
12.65 +0.16 (+1.28%)
After hours: 05:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-208,936
-188,917
-142,181
-70,645
-40,507
-
Depreciation & amortisation
410
383
531
199
155
-
Stock-based compensation
42,538
39,341
27,242
13,321
526
-
Change in working capital
3,162
9,418
6,564
2,695
-357
-
Accounts payable
141
2,316
-1,484
1,542
132
-
Other working capital
-173,795
-150,077
-109,900
-56,539
-13,581
-
Other non-cash items
-
3,000
-
8,000
30
11,914
Net cash provided by operating activities
-170,597
-146,853
-109,874
-48,539
-13,489
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-3,224
-26
-8,000
-92
-
Purchases of investments
-330,986
-443,838
-394,206
0
0
-
Sales/maturities of investments
563,043
575,440
139,158
0
0
-
Net cash used for investing activities
228,859
128,378
-255,074
-8,000
-92
-
Cash flows from financing activities
Common stock issued
-
161,409
161,610
167,045
0
-
Net cash used provided by (used for) financing activities
162,861
163,997
165,901
297,120
29,977
-
Net change in cash
221,123
145,522
-199,047
240,581
16,396
-
Cash at beginning of period
49,268
85,262
284,309
43,728
27,332
-
Cash at end of period
270,391
230,784
85,262
284,309
43,728
-
Free cash flow
Operating cash flow
-170,597
-146,853
-109,874
-48,539
-13,489
-
Capital expenditure
-
-3,224
-26
-8,000
-92
-
Free cash flow
-173,795
-150,077
-109,900
-56,539
-13,581
-